Last reviewed · How we verify
NCT04224233: iLiFE
A Home-based Physical Activity Programme for Patients With Advanced Interstitial Lung Diseases (iLiFE)
NA trial testing Home-based physical activity programme in Interstitial Lung Diseases (ILD) in 48 participants. Completed in 9 January 2024.
9 January 2024
Quick facts
| Lead sponsor | Aveiro University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 48 |
| Start date | 1 October 2020 |
| Primary completion | 9 January 2024 |
| Estimated completion | 9 January 2024 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- Home-based physical activity programme
- Usual care
Conditions studied
- Interstitial Lung Diseases (ILD) — all drugs for Interstitial Lung Diseases (ILD) →
Sponsor
Aveiro University
Who can join
18 and older, any sex, with Interstitial Lung Diseases (ILD). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Interstitial lung diseases (ILD) are a highly incapacitating group of chronic respiratory diseases, leading to disabling symptoms and impaired capacity to perform activities of daily living and health-related quality of life (HRQoL). It is known that people with ILD are highly inactive and sedentary, and in a severe stage of the disease, these people spend most of the time at home, increasing dependency on others, and decrease HRQoL. Physical activity is a cost-effective intervention, which increases the HRQoL, exercise capacity and ability to perform activities of daily living in people with chronic respiratory diseases. However, few home-based physical activity programmes are available, especially in people with ILD. Thus, it is urgent to develop innovative models of PA, closer to patients and adjusted to the patients' routines, to engage and change patients' physical activity levels, enhancing HRQoL. iLiFE might be promising as it focuses on establishing new behaviours, within selected contexts to stimulate home-based PA. Therefore, iLiFE will be developed, implemented and evaluated in people with ILD.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Cough in pulmonary rehabilitation: a retrospective analysis of responders and nonresponders.
Grave AS, Paixão C, Tecelão D, Marques A, et al · · 2025 · PMID 40129544 · DOI 10.1183/23120541.00308-2024
Verify or expand the search:
- PubMed search for NCT04224233
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Interstitial Lung Diseases (ILD)
Currently open trials in the same condition.
- NCT06948916 — Validity and Reliability of 6-minute Pegboard and Ring Test in Patients With Interstitial Lung Disease · recruiting
- NCT06948942 — Exercise Capacity, Muscle Oxygenation, and Physical Activity Between Patients With Interstitial Lung Disease · recruiting
- NCT06636487 — Expand Pulmonary Rehabilitation to Other Chronic Respiratory Diseases Than COPD · NA · active not recruiting
Other Aveiro University trials
Trials by the same sponsor.
- NCT06782893 — Chronic COUGH Management in Interstitial Lung DisEase · NA · not yet recruiting
- NCT07366580 — TOUCHminds: Help-seeking in Adolescents With Anxiety · NA · not yet recruiting
- NCT07505537 — Using BlazePod® for Pre-Season Screening of Lower Limb Injury Risk · not yet recruiting
- NCT07424274 — Physiotherapy Interventions on Functional Capacity, Balance and Mental Domains in Community-Dwelling Older Adults: A Ran · NA · not yet recruiting
- NCT06895720 — THE MYOFASCIAL SYSTEM AND MINIMIZING THE RISK OS INJURY IN SPORT · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04224233 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aveiro University
- Last refreshed: 6 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04224233.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing